4//SEC Filing
Ryali Sriram 4
Accession 0001209191-19-002201
CIK 0001305253other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:51 PM ET
Size
5.5 KB
Accession
0001209191-19-002201
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Stock Option ( Right to Buy)
2019-01-03+90,000→ 90,000 totalExercise: $10.46Exp: 2029-01-02→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 25% of the option shares on December 17, 2019 and vest as to the remaining shares in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001762893
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:51 PM ET
- Size
- 5.5 KB